Helling D K, Yesalis C E, Norwood G J, Burmeister L F, Lipson D P, Fisher W P, Jones M E
Drug Intell Clin Pharm. 1981 Jul-Aug;15(7-8):581-9. doi: 10.1177/1060028081015007-810.
This paper evaluates changes in quantities and appropriateness of dosages and quantities of prescription in capitation and control pharmacies. The data indicate that, under capitation, changes were made in the quantities of ingredients so that the quantities dispensed were significantly different from those prescribed. However, the number of such modifications to prescriptions was small, and the reader is cautioned against drawing broad conclusions. The analysis, then, considers changes in days' supply of prescription ingredients during the study period. There were significantly increases in the average day's supply of prescription ingredients for maintenance drugs dispensed under the capitation reimbursement scheme; however, no such differences were observed for non-maintenance drugs. Appropriateness of the dosages and quantities of prescriptions were then compared for capitation and fee-for-service pharmacies for the study period, and no significant differences were found. Thus, it is concluded that although capitation was associated with increases in the average days' supply of ingredients dispensed for maintenance prescriptions, such changes did not adversely affect the quality of drug therapy as measured by two sets of criteria.
本文评估了按人头付费药房和对照药房中处方剂量和数量的变化情况以及用药合理性。数据表明,在按人头付费模式下,药品成分的数量发生了变化,以至于配药量与处方量存在显著差异。然而,此类处方修改的数量较少,提醒读者不要得出宽泛的结论。随后,该分析考虑了研究期间处方成分供应天数的变化。在按人头付费报销方案下,维持药物的处方成分平均供应天数显著增加;然而,对于非维持药物,未观察到此类差异。然后比较了研究期间按人头付费药房和按服务收费药房处方剂量和数量的合理性,未发现显著差异。因此,得出的结论是,虽然按人头付费与维持性处方配药成分的平均供应天数增加有关,但根据两组标准衡量,此类变化并未对药物治疗质量产生不利影响。